Multivariate Cox regression analyses were also performed, including the following clinicopathological parameters: menopausal status (reference: postmenopausal), performance status (reference: 0), subtype classification (reference: luminal B), PTEN status (reference: loss), as well as each of the markers that were found to be significant or revealed a trend towards significance in the univariate analysis (p<0.10).
← all excerpts
Cyclin D1 differential activation and its prognostic impact in patients with advanced breast cancer treated with trastuzumab.
1
0.1000
0.1000